Dupixent® (dupilumab) eosinophilic esophagitis trial meets both co-primary endpoints

    NEXT STORY
    Disinfectants market worldwide is projected to grow by US$3.1 Billion
    PREV STORY
    Environmental Testing market worldwide is projected to grow by US$5.5 Billion
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

    author_avatar
    NASDAQ Market News

    eFFECTOR Publishes the Design and Profile of eFT508 in Peer Reviewed Journal of Medicinal Chemistry

    author_avatar
    NASDAQ Market News

    New SPINRAZA® (nusinersen) Data Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy

    NURTURE study participants were alive and did not require permanent ventilation, in contrast to ...

    author_avatar
    NASDAQ Market News